COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,526 Articles (22,380 medRxiv, 8,146 bioRxiv)

Most recent first Previous |  Page 33: Articles 321-330  | Next

Estimating rates of SARS-CoV-2 lineage spread from graph theory analysis and data mining of genetic sequence data streams
Goldberg, E. E., Kupperman, M., Ke, R.
10.1101/2025.02.07.25321892 — Posted: 2025-02-10
Causal associations of COVID-19 with health and disease outcomes: a systematic review and meta-analysis
Gao, L., Yan, J., Ye, M., Yang, X., Yao, Y., Xia, J., Jin, H., Ru, S., Zhang, M., Liu, Z., Zhang, Y.
10.1101/2025.02.07.25321697 — Posted: 2025-02-10
Effects of food insecurity on infant feeding confidence and practices during the COVID-19 pandemic and its waves
Hussain, M., Hyun, J., Arduin, E., Kyle, M. H., Abreu, W., Scripps, T., Nichols, P. H., Khan, A., Glassman, M., Stockwell, M. S., Walzer, L., Dumitriu, D., Fernandez, C. R.
10.1101/2025.02.07.25321881 — Posted: 2025-02-10
SARS-CoV-2 Aggregated Activity Level Across Ontario Canada, Measured with the US CDC Wastewater Viral Activity Level (WVAL) Metric
Delatolla, R., DeGroot, C. T., McKay, R. M., Servos, M. R., McAvoy, S., Krishnakumar, S., Jo, O., Fung, M., Hegazy, S., Fletcher, T., Simhon, A., Pileggi, V.
10.1101/2025.02.07.25321887 — Posted: 2025-02-10
Glycosylphosphatidylinositol biosynthesis restricts coronavirus infection via the regulation of LY6E
Ma, Y., Feng, F., Feng, H., Ma, X., Wang, Z., Han, Y., Zhu, Y., Wang, Y., Gao, Z., Zhang, Y., Zhao, J., Zhang, R.
10.1101/2025.02.08.637211 — Posted: 2025-02-10
SARS-CoV-2 infection of the brain: the K18-hACE2 mouse model to illustrate the role and response of the vasculature in neurotropic viral infection
De Neck, S., Penrice-Randal, R., Hetzel, U., Seehusen, F., Sharma, P., Bentley, E. G., Helminger, B., Kirby, A., Balistreri, G., Stewart, J. P., Kipar, A.
10.1101/2025.02.07.637145 — Posted: 2025-02-08
The physio-affective symptoms of Long COVID are strongly predicted by the severity of the acute infectious phase, and lowered antioxidants, nitric oxide, and alanine transaminase levels.
Maes, M., Tunvirachaisakul, C., Semeao, L. d. O., Michelin, A. P., Matsumoto, A. K., Brinholi, F. F., Barbosa, D. S., Zhang, Y., Sodsai, P., Hirankarn, N., Almulla, A. F.
10.1101/2025.02.07.25321870 — Posted: 2025-02-08
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project
Chen, J., Lei, Y., Wu, Q., Zhou, T., Zhang, B., Becich, M. J., Bisyuk, Y., Blecker, S., Chrischilles, E. A., Christakis, D. A., Cowell, L. G., Cummins, M. R., Fernandez, S. A., Fort, D., Gonzalez, S., Herring, S. J., Horne, B. D., Horowitz, C., Liu, M., Kim, S., Mirhaji, P., Mosa, A. S. M., Muszynski, J. A., Paules, C. I., Sato, A., Schwenk, H. T., Sengupta, S., Suresh, S., Taylor, B. W., Williams, D. A., He, Y., Morris, J. S., Jhaveri, R., Forrest, C. B., Chen, Y.
10.1101/2025.02.07.25321814 — Posted: 2025-02-08
Longitudinal epigenetic rewiring in lung immune cells in patients with post-COVID-19 condition
Nikesjö, F., Smiljanic, J., Sayyab, s., Martinez-Enguita, D., Gustafsson, M., Rosvall, M., Hedman, K., Lerm, M.
10.1101/2025.02.06.25321750 — Posted: 2025-02-07
AVERTED MORTALITY BY COVID-19 VACCINATION IN BELGIUM BETWEEN 2021 AND 2023
Stouten, V., Van Evercooren, I., Vernemmen, C., Braeye, T., Catteau, L., Roelants, M., Billuart, M., Lamot, T., Bustos Sierra, N., Hammami, N., Vermeiren, E., Rosas, A., Blot, K., Schmelz, A. I., Nasiadka, L., Nganda, S., van Loenhout, J. A. F.
10.1101/2025.02.06.25321208 — Posted: 2025-02-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).